Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials

Standard

Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials. / Anand, Sonia; Hiatt, William R; Dyal, Leanne; Bauersachs, R M; Berkowitz, Scott D; RH-Zweig, Kelly; Debus, Sebastian; Fox, Keith AA; Liang, Y; Mühlhofer, Eva; Mark R, Nehler; Haskell, Lloyd P; Patel, Manesh R; Szarek, Michael; Yusuf, Salim; Eikelboom, J W; Bonaca, Marc P.

In: EUR J CARDIOVASC NUR, Vol. 2021, zwab128, 31.08.2021.

Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

Harvard

Anand, S, Hiatt, WR, Dyal, L, Bauersachs, RM, Berkowitz, SD, RH-Zweig, K, Debus, S, Fox, KAA, Liang, Y, Mühlhofer, E, Mark R, N, Haskell, LP, Patel, MR, Szarek, M, Yusuf, S, Eikelboom, JW & Bonaca, MP 2021, 'Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials', EUR J CARDIOVASC NUR, vol. 2021, zwab128. https://doi.org/10.1093/eurjpc/zwab128

APA

Anand, S., Hiatt, W. R., Dyal, L., Bauersachs, R. M., Berkowitz, S. D., RH-Zweig, K., Debus, S., Fox, K. AA., Liang, Y., Mühlhofer, E., Mark R, N., Haskell, L. P., Patel, M. R., Szarek, M., Yusuf, S., Eikelboom, J. W., & Bonaca, M. P. (2021). Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials. EUR J CARDIOVASC NUR, 2021, [zwab128]. https://doi.org/10.1093/eurjpc/zwab128

Vancouver

Bibtex

@article{33a7f478e4a64663861935b9e79e757b,
title = "Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials",
author = "Sonia Anand and Hiatt, {William R} and Leanne Dyal and Bauersachs, {R M} and Berkowitz, {Scott D} and Kelly RH-Zweig and Sebastian Debus and Fox, {Keith AA} and Y Liang and Eva M{\"u}hlhofer and {Mark R}, Nehler and Haskell, {Lloyd P} and Patel, {Manesh R} and Michael Szarek and Salim Yusuf and Eikelboom, {J W} and Bonaca, {Marc P}",
year = "2021",
month = aug,
day = "31",
doi = "10.1093/eurjpc/zwab128",
language = "English",
volume = "2021",
journal = "EUR J CARDIOVASC NUR",
issn = "1474-5151",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials

AU - Anand, Sonia

AU - Hiatt, William R

AU - Dyal, Leanne

AU - Bauersachs, R M

AU - Berkowitz, Scott D

AU - RH-Zweig, Kelly

AU - Debus, Sebastian

AU - Fox, Keith AA

AU - Liang, Y

AU - Mühlhofer, Eva

AU - Mark R, Nehler

AU - Haskell, Lloyd P

AU - Patel, Manesh R

AU - Szarek, Michael

AU - Yusuf, Salim

AU - Eikelboom, J W

AU - Bonaca, Marc P

PY - 2021/8/31

Y1 - 2021/8/31

UR - https://pubmed.ncbi.nlm.nih.gov/34463737/

U2 - 10.1093/eurjpc/zwab128

DO - 10.1093/eurjpc/zwab128

M3 - Other (editorial matter etc.)

C2 - PMID: 34463737 DOI: 10.1093/eurjpc/zwab128

VL - 2021

JO - EUR J CARDIOVASC NUR

JF - EUR J CARDIOVASC NUR

SN - 1474-5151

M1 - zwab128

ER -